HCA Healthcare, Inc. Forecasted to Post Q1 2025 Earnings of $5.93 Per Share (NYSE:HCA)

HCA Healthcare, Inc. (NYSE:HCA) – Investment analysts at Zacks Research lifted their Q1 2025 earnings per share estimates for HCA Healthcare in a research report issued to clients and investors on Thursday, September 5th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings of $5.93 per share for the quarter, up from their previous forecast of $5.82. The consensus estimate for HCA Healthcare’s current full-year earnings is $22.48 per share. Zacks Research also issued estimates for HCA Healthcare’s Q2 2025 earnings at $6.14 EPS, Q4 2025 earnings at $6.89 EPS, FY2025 earnings at $24.74 EPS, Q1 2026 earnings at $6.50 EPS and Q2 2026 earnings at $6.58 EPS.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the previous year, the firm posted $4.29 earnings per share. The company’s quarterly revenue was up 10.3% compared to the same quarter last year.

Several other research firms have also recently commented on HCA. Robert W. Baird initiated coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Truist Financial upped their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. Deutsche Bank Aktiengesellschaft upped their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Finally, Royal Bank of Canada raised their price target on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $386.34 on Monday. The firm’s 50 day simple moving average is $358.16 and its 200 day simple moving average is $336.76. The firm has a market capitalization of $99.70 billion, a PE ratio of 19.26, a price-to-earnings-growth ratio of 1.45 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. HCA Healthcare has a 1-year low of $215.96 and a 1-year high of $403.05.

Institutional Trading of HCA Healthcare

Hedge funds have recently modified their holdings of the company. Sanctuary Advisors LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at $7,110,000. 3Chopt Investment Partners LLC acquired a new position in shares of HCA Healthcare during the second quarter valued at about $275,000. Granite Bay Wealth Management LLC acquired a new stake in HCA Healthcare in the 2nd quarter worth approximately $733,000. Advisory Alpha LLC raised its holdings in shares of HCA Healthcare by 55.8% in the second quarter. Advisory Alpha LLC now owns 949 shares of the company’s stock worth $305,000 after buying an additional 340 shares during the last quarter. Finally, Truist Financial Corp grew its holdings in shares of HCA Healthcare by 1.5% during the second quarter. Truist Financial Corp now owns 368,947 shares of the company’s stock valued at $118,535,000 after buying an additional 5,522 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,844 shares of company stock worth $3,185,932. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.